Armata Pharmaceuticals (ARMP) EPS (Basic): 2013-2018
Historic EPS (Basic) for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$0.24.
- Armata Pharmaceuticals' EPS (Basic) fell 500.00% to -$0.24 in Q4 2018 from the same period last year, while for Dec 2018 it was -$2.96, marking a year-over-year increase of 9.76%. This contributed to the annual value of -$0.52 for FY2024, which is 72.77% up from last year.
- According to the latest figures from Q4 2018, Armata Pharmaceuticals' EPS (Basic) is -$0.24, which was up 60.00% from -$0.60 recorded in Q3 2018.
- Armata Pharmaceuticals' EPS (Basic)'s 5-year high stood at $3.87 during Q3 2014, with a 5-year trough of -$8.22 in Q1 2016.
- For the 3-year period, Armata Pharmaceuticals' EPS (Basic) averaged around -$2.33, with its median value being -$1.21 (2017).
- Examining YoY changes over the last 5 years, Armata Pharmaceuticals' EPS (Basic) showed a top increase of 1,700.00% in 2014 and a maximum decrease of 10,500.00% in 2014.
- Armata Pharmaceuticals' EPS (Basic) (Quarterly) stood at -$0.25 in 2014, then tumbled by 116.00% to -$0.54 in 2015, then fell by 29.63% to -$0.70 in 2016, then spiked by 94.29% to -$0.04 in 2017, then slumped by 500.00% to -$0.24 in 2018.
- Its last three reported values are -$0.24 in Q4 2018, -$0.60 for Q3 2018, and -$2.08 during Q2 2018.